Avara Pharmaceutical Services, Inc.
Avara Pharmaceutical Services, Inc., a leading provider in the pharmaceutical contract manufacturing industry, is headquartered in the United States. Founded in 2017, Avara has quickly established itself as a key player in the market, specialising in the production of high-quality pharmaceutical products and services. With operational facilities across North America and Europe, the company focuses on offering comprehensive solutions, including sterile and non-sterile manufacturing, packaging, and supply chain management. Avara's commitment to quality and innovation sets it apart, as it leverages advanced technologies and stringent regulatory compliance to meet the diverse needs of its clients. The company has achieved significant milestones, including successful partnerships with major pharmaceutical firms, solidifying its position as a trusted partner in the industry. With a strong emphasis on customer satisfaction and operational excellence, Avara Pharmaceutical Services continues to drive advancements in pharmaceutical manufacturing.
DitchCarbon Score
How does Avara Pharmaceutical Services, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avara Pharmaceutical Services, Inc.'s score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Avara Pharmaceutical Services, Inc.'s reported carbon emissions
Avara Pharmaceutical Services, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions. Avara may be engaging in initiatives aligned with industry standards, but specific details regarding their climate strategies or commitments have not been disclosed. As the industry evolves, it is likely that Avara will adopt more defined climate goals and transparency in emissions reporting.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Avara Pharmaceutical Services, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
